...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Predisposition of spontaneously hypertensive rats to develop renal injury during nitric oxide synthase inhibition.
【24h】

Predisposition of spontaneously hypertensive rats to develop renal injury during nitric oxide synthase inhibition.

机译:一氧化氮合酶抑制过程中自发性高血压大鼠易患肾损伤。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chronic nitric oxide (NO) synthase (NOS) inhibition results in renal injury. Hypertension is an important risk factor for renal injury. We studied the influence of preexistent hypertension on the sensitivity for renal injury induced by chronic NOS inhibition in rats. Spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats were treated with 3, 10, 30 and 100 mg/l Nomega-nitro-L-arginine (L-NNA) until death. Systolic blood pressure and proteinuria were measured regularly and compared with time-control measurements in untreated SHR and WKY. In WKY, 3 and 10 mg/l L-NNA did not affect systolic blood pressure, while 30 and 100 mg/l L-NNA resulted in an increase in systolic blood pressure after 12 and 4 weeks, respectively. In contrast in SHR, every dose of L-NNA resulted in an increase in systolic blood pressure after 2 weeks. In WKY, 3 and 10 mg/l L-NNA did not affect proteinuria or survival, while 30 and 100 mg/l L-NNA resulted in an increase in proteinuria after 30 and 9 weeks, and a median survival of 36 and 12 weeks, respectively. In SHR, 3, 10, 30 and 100 mg/l L-NNA resulted in an increase in proteinuria after 30, 12, 3 and 3 weeks, and a median survival of 41, 20, 5 and 3 weeks, respectively. Thus, at every dose of the inhibitor, chronic NOS inhibition resulted in far earlier increases in systolic blood pressure and proteinuria and a marked increase in mortality in SHR as compared to WKY. Indeed, a very low dosage of L-NNA that caused no harm in WKY was followed by marked increases in proteinuria and blood pressure and decreased survival in SHR. Hypertension strongly increases the vulnerability to cardiovascular risk factors that compromise the NO-system.
机译:慢性一氧化氮(NO)合酶(NOS)抑制导致肾损伤。高血压是肾损伤的重要危险因素。我们研究了既往高血压对慢性NOS抑制所致大鼠肾损伤敏感性的影响。自发性高血压(SHR)和血压正常的Wistar-Kyoto(WKY)大鼠分别用3、10、30和100 mg / l的Nomega-nitro-L-精氨酸(L-NNA)治疗直至死亡。定期测量收缩压和蛋白尿,并与未经治疗的SHR和WKY中的时间对照测量值进行比较。在WKY中,3和10 mg / l L-NNA不会影响收缩压,而30和100 mg / l L-NNA分别会在12周和4周后导致收缩压升高。与SHR相反,每剂L-NNA导致2周后收缩压升高。在WKY中,3和10 mg / l L-NNA不会影响蛋白尿或生存,而30和100 mg / l L-NNA会在30和9周后导致蛋白尿增加,中位生存期为36和12周, 分别。在SHR中,3、10、30和100 mg / l L-NNA在30、12、3和3周后导致蛋白尿增加,中位生存期分别为41、20、5和3周。因此,与WKY相比,在每种剂量的抑制剂下,慢性NOS抑制都会导致收缩压和蛋白尿的上升更早,SHR的死亡率也显着上升。实际上,极低剂量的L-NNA不会对WKY造成伤害,其后蛋白尿和血压显着增加,SHR的生存期降低。高血压极大地增加了对危害NO系统的心血管危险因素的抵抗力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号